Most Ask
General Questions
We follow strict guidelines for the cultivation, extraction, and processing of our cannabis products, ensuring compliance with international standards. Our products undergo rigorous third-party testing to guarantee their safety, efficacy, and potency.
To export to Brazil under RDC 660, all products must comply with ANVISA’s regulations, including providing a prescription from a licensed doctor and the necessary import documentation. We handle all the paperwork and ensure that your product meets Brazil’s strict import laws.
Our CBD and THCV products meet the highest standards and are certified under GMP (Good Manufacturing Practice). We also adhere to international and Brazilian regulations, including RDC 660 for exportation to Brazil.
People Know
Other Questions
Yes, under RDC 660, Brazilian patients can import CBD and THCV products for personal medical use, provided they have a medical prescription from a certified healthcare provider and follow ANVISA’s guidelines.
You must consult with a licensed doctor in Brazil who can evaluate your condition and determine whether CBD or THCV is suitable for your treatment. They will provide you with the necessary prescription to legally import the products under RDC 660.
ANVISA limits the amount of CBD and THCV products that can be imported per prescription under RDC 660. The exact amount allowed depends on your prescription and medical needs, typically covering a few months of treatment.
CONTACT US NOW
Happy to Answer All Your Questions
CBD is known for its potential to reduce anxiety, alleviate pain, and support better sleep. THCV has been studied for its potential benefits in reducing appetite and supporting weight loss, as well as managing blood sugar levels.
Both CBD and THCV interact with the endocannabinoid system in the body, which helps regulate various physiological processes like mood, appetite, pain, and immune response. CBD primarily influences receptors related to pain and inflammation, while THCV affects energy and metabolism.
Yes, studies suggest that CBD may help alleviate chronic pain by reducing inflammation and interacting with neurotransmitters. THCV also has potential in this area but is more commonly studied for its effects on metabolism and energy.
CBG is known as the “mother of all cannabinoids” since it’s the precursor to other cannabinoids. It has shown promise in supporting gut health, reducing inflammation, and may have antibacterial properties. CBG is also being studied for its potential in treating glaucoma and neurodegenerative diseases.
CBN is often associated with promoting sleep and relaxation, making it beneficial for those with insomnia or sleep disorders. Unlike CBD, which has a broader range of effects, CBN is more specifically linked to sedative properties and may also support pain relief and inflammation reduction.